Joshua R. Disbrow - Aug 11, 2023 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Executive Officer, Director
Signature
/s/ Joshua R. Disbrow
Stock symbol
AYTU
Transactions as of
Aug 11, 2023
Transactions value $
$0
Form type
4
Date filed
8/15/2023, 07:34 PM
Previous filing
Jun 16, 2023
Next filing
May 17, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 1/3 on August 11, 2024, with the remaining options vesting in 24 equal monthly installments beginning September 11, 2024.